id	author	title	date	pages	extension	mime	words	sentence	flesch	summary	cache	txt
cord-340029-iv2x1vap	Farabi, Banu	Comment on “Psoriasis, COVID‐19 and acute respiratory distress syndrome: focusing on the risk of concomitant biological treatment”	2020-06-14		.txt	text/plain	814	24	22	COVID-19 and acute respiratory distress syndrome: focusing on the risk of concomitant biological treatment Evolution of COVID-19 infection in 4 psoriatic patients treated with biological drugs Biologics for psoriasis patients in the COVID-19 era: more evidence, less fears Risk of hospitalization and death from COVID-19 infection in patients with chronic plaque psoriasis receiving a biological treatment and renal transplanted recipients in maintenance immunosuppressive treatment COVID-19 and psoriasis: Is it time to limit treatment with immunosuppressants? Various scientific societies like American Academy of Dermatology (AAD) and International League of Dermatological Societies (ILDS) have issued guidelines to discontinue only in COVID-19 positive patients but can be carefully considered on a case-by-case basis if the patient is COVID-19 negative and with no symptoms by weighing risk vs. benefit ratio.	cache/cord-340029-iv2x1vap.txt	txt/cord-340029-iv2x1vap.txt
